Kohzuki M, Abe K, Yasujima M, Kasai Y, Hiwatari M, Kanazawa M, Sato M, Omata K, Kudo K, Takeuchi K
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Tohoku J Exp Med. 1989 Apr;157(4):301-11. doi: 10.1620/tjem.157.301.
To assess possible roles of atrial natriuretic factor (ANF) in the regulation of blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats, we performed two series of experiments. First, we studied acute hypotensive, and natriuretic and diuretic effects of ANF in pentobarbital-anesthetized DOCA-salt hypertensive rats and age-matched controls. A synthetic rat ANF was intravenously administered as a bolus at doses of 0.5, 2.5 and 5.0 micrograms/kg. In DOCA-salt rats, a significant decrease in mean arterial pressure was observed at a dose of 5.0 micrograms/kg, whereas at a dose of 2.5 micrograms/kg in control rats. On the other hand, the diuretic and natriuretic effects of ANF were observed at a dose of 2.5 micrograms/kg in DOCA-salt rats and 5.0 micrograms/kg in control rats. Second, we examined chronic effect of ANF on the development of hypertension in DOCA-salt rats. The DOCA-salt rats, given 1% NaCl solution for drinking, were continuously infused with ANF (15, 75 and 150 micrograms/kg/day) or vehicle (physiological saline) into the jugular vein by osmotic minipumps for up to 14 days. In DOCA-salt treated rats, ANF at doses of 75 and 150 micrograms/kg/day attenuated significantly the development of hypertension, although at a dose of 15 micrograms/kg/day did not. The hypotensive effect of ANF was sustained throughout the experimental period and the effect of ANF at a dose of 150 micrograms/kg/day was more prominent than that of this peptide at a dose of 75 micrograms/kg/day. ANF did not induce any significant changes in urine volume, fluid intake and urinary excretion of sodium and potassium in DOCA-salt rats when compared to those in vehicle-infused DOCA-salt rats. These results indicate that DOCA-salt rats are more sensitive to ANF in diuretic and natriuretic effects, and less sensitive to ANF in hypotensive effect compared to control rats. Moreover, it is suggested that ANF can affect the regulation of blood pressure by its vascular effect in the development of hypertension in DOCA-salt rats.
为了评估心房利钠因子(ANF)在醋酸脱氧皮质酮(DOCA)-盐性高血压大鼠血压调节中的可能作用,我们进行了两组实验。首先,我们研究了ANF对戊巴比妥麻醉的DOCA-盐性高血压大鼠和年龄匹配的对照大鼠的急性降压、利钠和利尿作用。合成的大鼠ANF以0.5、2.5和5.0微克/千克的剂量静脉推注给药。在DOCA-盐大鼠中,在5.0微克/千克的剂量下观察到平均动脉压显著降低,而在对照大鼠中,2.5微克/千克的剂量下观察到该现象。另一方面,在DOCA-盐大鼠中,2.5微克/千克的剂量下观察到ANF的利尿和利钠作用,而在对照大鼠中,5.0微克/千克的剂量下观察到该现象。其次,我们研究了ANF对DOCA-盐大鼠高血压发展的慢性影响。给饮用1%氯化钠溶液的DOCA-盐大鼠通过渗透微型泵持续颈静脉输注ANF(15、75和150微克/千克/天)或载体(生理盐水),持续14天。在接受DOCA-盐处理的大鼠中,75和150微克/千克/天剂量的ANF显著减弱了高血压的发展,尽管15微克/千克/天的剂量没有这种作用。ANF的降压作用在整个实验期间持续存在,并且150微克/千克/天剂量的ANF的作用比75微克/千克/天剂量的该肽的作用更显著。与输注载体的DOCA-盐大鼠相比,ANF在DOCA-盐大鼠中未引起尿量、液体摄入量以及钠和钾的尿排泄的任何显著变化。这些结果表明,与对照大鼠相比,DOCA-盐大鼠对ANF的利尿和利钠作用更敏感,而对ANF的降压作用较不敏感。此外,提示ANF在DOCA-盐大鼠高血压发展过程中可通过其血管作用影响血压调节。